Cancer StemCells

Published: 05-May-2021

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@pulsus.com

Abstract

The global Cancer market extent was estimated at USD 8.65 billion in the year 2018 and is expected to expand at a CAGR of 8.8% over the predicted period. According to the Wide Cells Group, between the years 2005 and 2013, there has been a 300% rise in the number of diseases that can be cured by stem cells.

The global Cancer market extent was estimated at USD 8.65 billion in the year 2018 and is expected to expand at a CAGR of 8.8% over the predicted period. According to the Wide Cells Group, between the years 2005 and 2013, there has been a 300% rise in the number of diseases that can be cured by stem cells.

Importance & Scope

Cancer is second leading cause of death worldwide. Treatments that work for some cancers don’t work for the others and

sometimes those treatments simply stop working and only a global search for answers will help us get to grip this disease. The conference will provide with an opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of oncology. Conference will also explore the new ideas and concepts on

global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted

Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Nanotechnology, Cancer Treatment and Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics &

Therapeutics, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

This Conference brings together the specialists from all the aspects to discuss about the future of Oncology and Cancer in today’s world to thrive and survive with a better health. Directors specialists, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, Healthcare Institutions, Market Research and Consulting Firms, Pharmaceutical Companies and all other interested participants willing to enhance and update the knowledge may attend the conference.

ONCOLOGY RESEARCH:

The branch of health care that determines the safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed Clinical Research .These are used for the treatment , prevention, diagnosis and relieving symptoms of the diseases. Clinical research may differ from clinical practice. Clinical Practice uses established process , whereas in case of clinical research evidence is collected for establishing the new treatment using “biological marker” .i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient – and is measured accurately.

Market Analysis Report:

The branch of health care that determines the safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed Clinical Research .These are used for the treatment , prevention, diagnosis and relieving symptoms of the diseases. Clinical research may differ from clinical practice. Clinical Practice uses established process , whereas in case of clinical research evidence is collected for establishing the new treatment using “biological marker” .i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient – and is measured accurately

Cancer Diagnostic Market: By Technology:

A. Platform Based:

In situ Hybridization

Flow Cytometry

Next-generation Sequencing

Microarrays

Others

B. Instrument Based:

Biopsy

Mammography

PET

Ultrasound

MRI

CT

Cancer Diagnostic Market:

By Region:

Based on region, the cancer diagnostics market is classified into North America, Europe, Asia, and Rest of the World. Rest of the World includes Latin America, Pacific countries, and Middle East and Africa. North America is predicted as the largest share in the cancer diagnostics market, followed by Europe and Asia.

List of the major performers in the cancer diagnostics system market globally are:

Sanofi (France)

Novartis (Germany)

Pfizer Inc. (U.S.)

Eli Lilly & Company (U.S.)

ImClone Systems Inc. (U.S.)

GlaxoSmithKline (U.K)

AstraZeneca (U.K)

Schering-Plough (U.S.)

Boehringer Ingelheim (Germany)

Bristol-Myers Squibb

Teva Pharmaceuticals Industries (Japan)

F. Hoffmann-La Roche Ltd (Switzerland)

Merck & Co., Inc. (U.S.)

Chemo Espana SL (Spain)

CELGENE CORPORATION (U.S.)

Amgen Inc (U.S.)

Bayer AG (Germany)

Takeda Pharmaceutical Company Limited (Japan)

List of Associations Worldwide:

American Association for Cancer Research

Virginia Cancer Institute

American Brain Tumor Association

American Society of Paediatric Haematology/Oncology

Association of Cancer Physicians

American Childhood Cancer Organization

American Society of Clinical Oncology

Australasian Lung Cancer Trials Group

International Cancer Research Partnership (ICRP)

American Association for Cancer Research (AACR)

American Society of Clinical Oncology (ASCO)

International Agency for Research on Cancer (IARC)

Cancer Society of New Zealand

Irish Cancer Society

Australian Cervical Cancer Foundation

Medical Centre Cologne

Cancer Research UK

Australian Prostate Cancer Research

Peter McCollum Cancer Centre

The European Cancer Organization (ECCO)

German Cancer Research Centre

List of Medical Universities worldwide:

Harvard University

University of Minnesota

Mayo Medical School

Pittsburgh School of Medicine

Yale University

University of Cambridge

University of Oxford Stanford University

Yale University

Emory University

John Hopkins University

Kings College London

Feinberg School of Medicine

University of Wisconsin

UNC School of Medicine

Karolinska University

Cancer related companies:

Roche | Sanofi | Johnson & Johnson | Merck & Co. (MSD) | Novartis | AbbVie | Gilead Sciences | GlaxoSmithKline (GSK) | Amgen | Pfizer | F. Hoffmann-La Roche Ltd | Celgene Corp | Novartis AG | Bristol-Myers Squibb Co | Samsung Medical Centre